• Blog
  • x

    We are working from home under lockdown. Our team is continuously tracking the impact of COVID-19 across different industries and we will incorporate those insights in our reports. For any specific query, mail us at [email protected]

    Drug Discovery Informatics Market | Covid-19 Impact Analysis

    Drug Discovery Informatics Market | Covid-19 Impact Analysis

    Drug Discovery Informatics Market | Covid-19 Impact Analysis
    Report code - SRHL168 Delivery - 2 Weeks
    Drug Discovery Informatics Market Size, Share, Trend, Forecast, & Industry Analysis&nb See more...
    Purchase Report
    notch

    Drug Discovery Informatics Market Insights

    Drug Discovery Informatics market is likely to witness an impressive CAGR of 9.3% during the forecast period. The prime factors that are likely to drive the market are the increasing expenditure in R&D activities, growing support for research in the pharmaceutical areas, especially for rare diseases, and the escalating use of informatics for discovery of new drugs.

    Drug Discovery Informatics Market - Snapshot

    Growth

    9.3% for the next five years

    Major Function Type

    Sequencing & Target Data Analysis

    Dominant End-User Type

    Pharmaceutical Companies

    Region with the highest demand

    North America

    Key Players

    Accenture PLC, Albany Molecular Research Inc., Charles

    River Laboratories International, Inc., Clarivate Analytics LLC,

    Eurofins Scientific SE, IBM Corporation, Jubilant Life Sciences

    Limited, PerkinElmer Inc., Schrödinger, Inc., Thermo Fisher

    Scientific Inc. 

    Wish to Get a Free Sample? Click here

    Market Share Analysis

    Drug Discovery Informatics Market Share: By Function Type

    Based on the function type, the market is segmented as sequencing & target data analysis, docking, molecular modelling, library & database preparation, and others. The sequencing & target data analysis segment held the largest share of the market in 2019, owing to the increased application of sequencing analysis and ease of handling information from different sources and domains. The segment is likely to maintain its leading position during the forecast period as well.

    Drug Discovery Informatics Market Share: By End-User Type

    Based on the end-user type, the drug discovery informatics market is segmented as pharmaceutical companies, biotechnology companies, contract research organizations (CROs), and others. The pharmaceutical companies’ segment led the market in 2019, and is expected to dominate the market over the forecast period. The growth of the segment is driven by the extensive use of software for pre-clinical research & developmental activities, target identification, compound screening and lead identification, and streamlining drug discovery processes.

    Drug Discovery Informatics Market Share: By Region

    In terms of regions, North America held the largest share of the market in 2019, followed by Europe. North America is expected to command the market during the forecast period as well. The dominant position of North America is due to the presence of major CROs and increasing expenditure by pharmaceutical and biopharmaceutical companies. On the other hand, Asia-Pacific is likely to grow at the highest CAGR during the forecast period, driven by the rapid growth of pharmaceutical and biopharmaceutical industries and growing number of CROs in the region, with China and India being the major countries offering promising growth opportunities over the forecast period.

    Some of the major players in the drug discovery informatics market are-

    • Accenture PLC
    • Albany Molecular Research Inc.
    • Charles River Laboratories International, Inc.
    • Clarivate Analytics LLC
    • Eurofins Scientific SE
    • IBM Corporation
    • Jubilant Life Sciences Limited
    • PerkinElmer Inc.
    • Schrödinger, Inc.
    • Thermo Fisher Scientific Inc. 

     

    Market Scope & Segmentation

    Drug discovery informatics encompasses the creation of systems that can work more capably with large sets of clinical trial and treatment data. Discovery and development of drugs is a highly complex process, requiring creation of large amount data and information.

    This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.

    Drug Discovery Informatics Market Research Report - Features

    Market Segmentation

    5

    Regions Covered

    4

    Countries/Sub-Regions Covered

    17

    No. of Figures & Tables

    >150

    Company Profiles

    10

    Wish to Get a Free Sample? Click here

    The drug discovery informatics market is segmented into the following categories. 

    Drug Discovery Informatics Market Size, Share, & Forecast, by Function Type:

    • Sequencing & Target Data Analysis (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Docking (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Molecular Modelling (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Library & Database Preparation (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Others (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)

    Drug Discovery Informatics Market Size, Share, & Forecast, by Application Type:

    • Drug Discovery (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Drug Development
      • (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
      • (Application Type Analysis: Preclinical Testing and Clinical Trials)

    Drug Discovery Informatics Market Size, Share, & Forecast, by Solution Type:

    • Software (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Services (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)

    Drug Discovery Informatics Market Size, Share, & Forecast, by End-User Type:

    • Pharmaceutical Companies (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Biotechnology Companies (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Contract Research Organizations (CROs) (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Others (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)

    Drug Discovery Informatics Market Size, Share, & Forecast, by Region:

    • North America (Country Analysis: the USA, Canada, and Mexico) 
    • Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and Rest of Europe)
    • Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and Rest of Asia-Pacific)
    • Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

     

    Research Methodology

    This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both the qualitative and quantitative insights.

     

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:

    • Market structure: Overview, industry life cycle analysis, supply chain analysis
    • Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
    • Market trend and forecast analysis
    • Market segment trend and forecast
    • Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
    • Attractive market segments and associated growth opportunities
    • Emerging trends
    • Strategic growth opportunities for the existing and new players
    • Key success factors

     

    Report Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to 3 players)
    • SWOT analysis of key players (up to 3 players)

    Market Segmentation

    • Current market segmentation of any one of the solution types by end-user type.  

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected]


    Frequently Asked Questions (FAQs)

    What will be the growth of Drug discovery informatics market in the foreseeable future?

    Driven by the factors like increasing expenditure in R&D activities & growing support for research in the pharmaceutical areas, the drug discovery informatics market is expected to witness an impressive growth of 9.3% CAGR.

    Which country/region is expected to remain the largest Drug discovery informatics market?

    North America is expected to remain the largest market for drug discovery informatics during the next five years.

    Who are the key players in the Drug discovery informatics market?

    Accenture PLC, Albany Molecular Research Inc., Charles River Laboratories International, Inc., Clarivate Analytics LLC, Eurofins Scientific SE, IBM Corporation, Jubilant Life Sciences Limited, PerkinElmer Inc., Schrdinger, Inc., and Thermo Fisher Scientific Inc are among the key players in the drug discovery informatics market.

    Which end-user is expected to remain dominant in the market?

    The pharmaceutical companies segment is expected to remain the dominant end-user in the drug discovery informatics market in the coming years.

    •   
    FREE SAMPLE